Study of TEV-50717 in Relieving Tics Associated With Tourette Syndrome

Study Title
A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
Teva Identifier
TV50717-CNS-30060 | 2017-002976-24
ClinicalTrials.gov Identifier
NCT03571256
Study Status
Completed
Trial Condition(s)
Tourette Syndrome
Interventions
Drug: TEV-50717 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child
Age Range
6 Years to 16 Years
Trial Duration
May 31, 2018 - December 9, 2019
Phase
Phase 3

Additional info

Study Type

Interventional